Cancer BiologybioRxivPreprint
A first-in-class Wiskott-Aldrich syndrome protein (WASp) activator with anti-tumor activity in hematological cancers
F. Spriano, G. Sartori, L. Barnabei…·E. Gaudio
This paper develops EG-011, a first-in-class WASp activator with anti-tumor activity in hematological cancers, including resistant models.
DOI 10.1101/2022.11.25.517686